Mark Crockett, MDMolecular ImagingTargeted radiopharmaceuticals offer new hope for longer 'healthspans'Precision radiopharmaceuticals accurately target tumors while minimizing damage to healthy tissue, presenting an opportunity to extend not just lifespans but “healthspans,” Mark Crockett, MD, explains in this article.March 15, 2024Page 1 of 1Top StoriesDigital X-RayCombined fluoride and lead exposure reduces bone health in youthCo-exposure to fluoride and lead exacerbates changes in BMD more than single exposure, suggesting synergistic effects on bone impairment.UltrasoundMedical societies applaud proposed CEUS training recommendationsMRICochrane updates 2013 prostate cancer screening reviewMRIISMRM: fMRI flags brain network failures in fibromyalgia, long COVIDSponsor ContentRadiology is Under Pressure